191 related articles for article (PubMed ID: 36300019)
1. Isolipoic acid-linked gold nanoparticles bearing the thomsen friedenreich tumor-associated carbohydrate antigen: Stability and
Mondal UK; Barchi JJ
Front Chem; 2022; 10():1002146. PubMed ID: 36300019
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.
Biswas S; Medina SH; Barchi JJ
Carbohydr Res; 2015 Mar; 405():93-101. PubMed ID: 25556664
[TBL] [Abstract][Full Text] [Related]
3. Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles.
Sundgren A; Barchi JJ
Carbohydr Res; 2008 Jul; 343(10-11):1594-604. PubMed ID: 18502409
[TBL] [Abstract][Full Text] [Related]
4. A Stable Gold Nanoparticle-Based Vaccine for the Targeted Delivery of Tumor-Associated Glycopeptide Antigens.
Trabbic KR; Kleski KA; Barchi JJ
ACS Bio Med Chem Au; 2021 Dec; 1(1):31-43. PubMed ID: 34927166
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
Brinãs RP; Sundgren A; Sahoo P; Morey S; Rittenhouse-Olson K; Wilding GE; Deng W; Barchi JJ
Bioconjug Chem; 2012 Aug; 23(8):1513-23. PubMed ID: 22812418
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the Thomsen-Friedenreich-antigen (TF-antigen) and binding of Galectin-3 to TF-antigen presenting neo-glycoproteins.
Hoffmann M; Hayes MR; Pietruszka J; Elling L
Glycoconj J; 2020 Aug; 37(4):457-470. PubMed ID: 32367478
[TBL] [Abstract][Full Text] [Related]
7. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL
Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216
[TBL] [Abstract][Full Text] [Related]
8. Glycoamino Acid Analogues of the Thomsen-Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides.
Siddiqui MA; Ambre S; Keay SK; Rhyne JM; Zhang CO; Barchi JJ
ACS Omega; 2017 Sep; 2(9):5618-5632. PubMed ID: 28983523
[TBL] [Abstract][Full Text] [Related]
9. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.
Peletskaya EN; Glinsky VV; Glinsky GV; Deutscher SL; Quinn TP
J Mol Biol; 1997 Jul; 270(3):374-84. PubMed ID: 9237904
[TBL] [Abstract][Full Text] [Related]
10. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition of the Thomsen-Friedenreich antigen-threonine conjugate by adhesion/growth regulatory galectin-3: nuclear magnetic resonance studies and molecular dynamics simulations.
Yongye AB; Calle L; Ardá A; Jiménez-Barbero J; André S; Gabius HJ; Martínez-Mayorga K; Cudic M
Biochemistry; 2012 Sep; 51(37):7278-89. PubMed ID: 22916968
[TBL] [Abstract][Full Text] [Related]
12. Thiol-Mediated Multidentate Phosphorylcholine as a Zwitterionic Ligand for Stabilizing Biocompatible Gold Nanoparticles.
Zhou W; Ling L; Du Y; He W; Xia Q; Yao C; Li X
Langmuir; 2019 Oct; 35(40):13031-13039. PubMed ID: 31537058
[TBL] [Abstract][Full Text] [Related]
13. [Optical Analysis of the Interaction of Mercaptan Derivatives of Nanogold Particles with Carcinoembryonic Antigen].
Zeng HJ; Zhao RL; Wang DS; Li CX; Liu YY
Guang Pu Xue Yu Guang Pu Fen Xi; 2016 Feb; 36(2):478-81. PubMed ID: 27209753
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.
Yu LG; Andrews N; Zhao Q; McKean D; Williams JF; Connor LJ; Gerasimenko OV; Hilkens J; Hirabayashi J; Kasai K; Rhodes JM
J Biol Chem; 2007 Jan; 282(1):773-81. PubMed ID: 17090543
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen.
Bian CF; Zhang Y; Sun H; Li DF; Wang DC
PLoS One; 2011; 6(9):e25007. PubMed ID: 21949831
[TBL] [Abstract][Full Text] [Related]
16. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
Kumar SR; Gallazzi FA; Quinn TP; Deutscher SL
J Nucl Med; 2011 Nov; 52(11):1819-26. PubMed ID: 21984800
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-related expression of the Thomsen-Friedenreich glycotope in developing human lung and in lung carcinoma: lack of association with malignancy.
Toma V; Sata T; Vogt P; Komminoth P; Heitz PU; Roth J
Cancer; 1999 May; 85(10):2151-9. PubMed ID: 10326693
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of an achiral isomer of lipoic acid as an anchor group for SAM formation on gold surfaces.
Joly KM; Mirri G; Willener Y; Horswell SL; Moody CJ; Tucker JH
J Org Chem; 2010 Apr; 75(7):2395-8. PubMed ID: 20210295
[TBL] [Abstract][Full Text] [Related]
19. Thermal stability of DNA functionalized gold nanoparticles.
Li F; Zhang H; Dever B; Li XF; Le XC
Bioconjug Chem; 2013 Nov; 24(11):1790-7. PubMed ID: 24102258
[TBL] [Abstract][Full Text] [Related]
20. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles.
Liu X; Huang N; Wang H; Li H; Jin Q; Ji J
Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
